CLINICAL_TRIALS
trial_result
· 2023-06-12
Clinical Trial Update: Nicotinic Agonist Effects on BMI and Neuronal Response [Phase 1]
Summary
Phase 1 trial investigating nicotinic agonist effects on BMI and neuronal response in obesity.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Obesity | Phase 1 | Status: COMPLETED | Results posted: 2023-06-12